References
- Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 μg/d and the copper TCu 380Ag intrauterine devices: A multicenter study. Fertil Steril 1994;61:70–77.
- The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: Rationale and consensus definition. J Am Med Assoc 1993;269:390–391.
- World Health Organization. Medical eligibility criteria for contraceptive use. 3rd edn. Geneva: WHO, 2004.
- Tatum HJ. Milestones in intrauterine device development. Fertil Steril 1983;39:141–143.
- Meirik O. Intrauterine devices – upper and lower genital tract infections. Contraception 2007;75:S41–S47.
- Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000;356:1013–1019.
- Kaunitz AM. Beyond the pill: New data and options in hormonal and intrauterine contraception. Am J Obstet Gynecol 2005;192:998–1004.
- Gupta S, Kirkman R. Intrauterine devices – update on clinical performance. Obstetrician Gynaecologist 2002;4:37–43.
- Stevens DL. Invasive group A streptococcal infections: The past, present and future. Pediatr Infect Dis J 1994;13:561–566.
- Murray PR. Streptococcus. In Murray PR, Rosenthal KS, Pfaller MA, eds. Medical Microbiology. Philadelphia, PA: Elsevier Mosby 2005:241.
- Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 1992;14:2–13.
- Crum NF, Chun HM, Gaylord TG, Hale BR. Group A streptococcal toxic shock syndrome developing in the third trimester of pregnancy. Infect Dis Obstet Gynecol 2002;10:209–216.
- Herzer CM. Toxic shock syndrome. Broadening the differential diagnosis. J Am Board Fam Pract 2001;14:131–136.
- Begley JS, Barnes RC. Group B streptococcus toxic shock-like syndrome in a healthy woman. J Reprod Med 2007;52:323–325.
- Mourton S, Rich W. Group A streptococcal toxic shock syndrome after an office endometrial biopsy A case report. J Reprod Med 2006;51:665–668.